Preclinical evaluation of the ROCK1 inhibitor, GSK269962A, in acute myeloid leukemia

Ting Pan(Sun Yat-sen University), Mingshan Niu(Xuzhou Medical College)

Frontiers in Pharmacology

December 6, 2022

10.3389/fphar.2022.1064470

Cited by 12

Related Papers

Myeloid-derived suppressor cells are essential for maintaining feto-maternal immunotolerance via STAT3 signaling in mice

|Journal of Leukocyte Biology|2016|85

MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation

|Frontiers in Oncology|2020|14

Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death

|Blood Advances|2024|4